Marc Hardwick
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 10%
- Long-Term Effects of COVID-19
- Autoimmune Neurological Disorders and Treatments
Papers in
-
- Long-Term Effects of COVID-19 4
- Autoimmune Neurological Disorders and Treatments 3
-
- COVID-19 Clinical Research Studies 6
- Co-authors
- Belinda Lennox (1 shared paper)Emma Claire Palmer-Cooper (1 shared paper)Ian Galea (4 shared papers)Thomas Arthur Pollak (1 shared paper)Alexis E. Cullen (1 shared paper)Benedict Daniel Michael (1 shared paper)Rhys Huw Thomas (2 shared papers)Sarah Lilian Pett (2 shared papers)
- Journals
- The Lancet (2 papers)Journal of the Neurological Sciences (2 papers)Nature Communications (1 paper)Brain Communications (1 paper)Neuropathology and Applied Neurobiology (1 paper)
- Partner nations
- United KingdomSpainTaiwan
In The Last Decade
Marc Hardwick
17 papers receiving 491 citations
Marc Hardwick's Hit Papers
Peers
Comparison fields: 5 of 44
- Infectious Diseases 188
- Neurology 92
- Biological Psychiatry 1
- Epidemiology 27
- Aging 1
Countries citing papers authored by Marc Hardwick
This map shows the geographic impact of Marc Hardwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Hardwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Hardwick more than expected).
Fields of papers citing papers by Marc Hardwick
This network shows the impact of papers produced by Marc Hardwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Hardwick. The network helps show where Marc Hardwick may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Hardwick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 2 | 2023 | 84 | |
| 3 | 2021 | 37 | |
| 4 | 2023 | 32 | |
| 5 | 2023 | 25 | |
| 6 | 2020 | 24 | |
| 7 | 2024 | 24 | |
| 8 | 2022 | 20 | |
| 9 | 2019 | 8 | |
| 10 | 2021 | 8 | |
| 11 | 2025 | 5 | |
| 12 | 2025 | 4 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 2 | |
| 15 | 2021 | 1 | |
| 16 | 2021 | 1 | |
| 17 | Fewer COVID-19 neurological complications with dexamethasone and remdesivir | 2023 | 1 |
About Marc Hardwick
Marc Hardwick is a scholar working on Neurology, Infectious Diseases, Epidemiology, Surgery and Nuclear Energy and Engineering, having authored 17 papers that have together received 510 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Long-Term Effects of COVID-19 (4 papers), Autoimmune Neurological Disorders and Treatments (3 papers), Influenza Virus Research Studies (1 paper) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (188 citations), Neurology (92 citations), Biological Psychiatry (1 citation), Epidemiology (27 citations) and Aging (1 citation). Marc Hardwick has collaborated with scholars based in United Kingdom, Spain and Taiwan. Frequent co-authors include Belinda Lennox, Emma Claire Palmer-Cooper, Ian Galea, Thomas Arthur Pollak, Alexis E. Cullen, Benedict Daniel Michael, Rhys Huw Thomas, Sarah Lilian Pett, John Kenneth Baillie and Peter Openshaw. Their work appears in journals such as The Lancet, Journal of the Neurological Sciences, Nature Communications, Brain Communications and Neuropathology and Applied Neurobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.